🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07089797
Recruiting Not applicable

Nurse-supported Mobile App for Self-help CBT-I in Informal Cancer Caregivers

NCT07089797 · tracked via the Priya Life Science China tracker
Sponsor
The University of Hong Kong
Phase
Not applicable
Started
2025-08-11
Last updated
2026-02-18

Condition(s) studied

Insomnia ChronicCancer Caregivers

Investigational drug(s) / intervention(s)

Nurse-Supported Mobile App for Self-Help CBT-ISleep hygiene education

Nurse-Supported Mobile App for Self-Help CBT-I: The intervention consists of two components: 1) a mobile app (i.e., WeChat mini program) delivered 6-week self-help CBT-I program; and 2) Weekly nurse support session (up to 20 minutes each) across a 6 week intervention period.

Sleep hygiene education: The participants in the control group will receive only sleep hygiene (one-page handout) via WeChat. Access to the CBT-I WeChat mini program will be offered to these participants after the completion of the 3-month follow-up assessment.

Study summary

This mixed-methods randomized controlled trial investigates whether a nurse-supported mobile app for self-help cognitive behavioral therapy for insomnia (CBT-I) effectively reduces insomnia severity among informal cancer caregivers, compared to sleep hygiene education.\<br\>\<br\>

The primary research question is:\<br\> Does nurse-supported mobile app for self-help CBT-I lower insomnia severity among cancer caregivers compared to sleep hygiene education at post-intervention and 3-month follow-up?\<br\>\<br\>

A total of 208 participants will:\<br\>

1. Be randomly assigned to one of two groups:\<br\> (i) the nurse-supported mobile app-based self-help CBT-I group, which involves a 6-week CBT-I program delivered via a WeChat mini program along with weekly nurse support sessions (up to 20 minutes each); or\<br\> (ii) the sleep hygiene education group.\<br\>
2. Complete assessments at baseline, post-intervention, and 3-month follow-up to measure changes in insomnia severity (primary outcome). Secondary outcomes include subjective sleep outcomes, psychological well-being, caregiver burden, fatigue, health-related quality of life, and participants' acceptability and satisfaction.\<br\>\<br\>

As recommended for trials of complex interventions, investigators will conduct a process evaluation in alignment with the Medical Research Council (MRC) guidance. The key functions of the process evaluation include: \*(1) implementation, (2) mechanisms of impact, and (3) context.\*

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Informal caregiver (e.g., family member or a friend) who co-resides with a cancer survivor of any site or stage and provides at least 4 hours of unpaid daily care. If two or more caregivers are available for a cancer survivor, the one providing most of the daily care will be included. * Able to understand the research procedures, and read and communicate in Chinese * Able to use WeChat * Insomnia severity index scores \> 7 Exclusion Criteria: * Another sleep disorder (e.g., obstructive sleep apnea, restless leg syndrome, rapid eye movement behavior disorder), besides insomnia, that is not adequately treated * Psychotic disorders (e.g., bipolar disorder, schizophrenia); Suicidal ideation with intent and plan OR attempted suicide within the past 2 months * Currently taking any psychotropic drugs (e.g., antidepressants, anxiolytics, sleep medications) * Unstable or acute medical condition or condition requiring surgery in the next 6 months; Pregnancy; or Epilepsy * Currently participating in any other interventional program * Prior experience with CBT-I * Night, evening, early morning or rotating shift work * Currently caring for a cancer patient receiving hospice care

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shanghai University Shanghai Cancer Centre Shanghai China Recruiting

More The University of Hong Kong trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07089797 on ClinicalTrials.gov ↗ ← All trials in China